Chris E. Lawrence

Discovery of a potent and selective Aurora kinase inhibitor

Johan D. Oslob, M.J. Romanowski, Darin A. Allen et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 108 citations · Full text

Medicine, Medicinal Chemistry, Oncology +9

Discovery and optimization of a series of quinazolinone-derived antagonists of CXCR3

Michael G. Johnson, An‐Rong Li, Jiwen Liu et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 105 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12

The impact of Fc engineering on an anti-CD19 antibody: increased Fcγ receptor affinity enhances B-cell clearing in nonhuman primates

Jonathan Zalevsky, Irene Leung, Sher Karki et al. · Blood · 2008 · 101 citations · Full text

Life Sciences, Immunology, Pathology +17

Single low-dose rHuIL-12 safely triggers multilineage hematopoietic and immune-mediated effects

Mamata Gokhale, Vladimir Vainstein, Jamie Tom et al. · Experimental Hematology and Oncology · 2014 · 30 citations · Full text

Medicine, Hematology, Oncology +17

Duloxetine for the Treatment of Patients with Suspected Sphincter of Oddi Dysfunction: A Pilot Study

Qi Pauls, Valerie Durkalski‐Mauldin, Olga Brawman‐Mintzer et al. · Digestive Diseases and Sciences · 2016 · 24 citations

Medicine, Pharmacology, Pharmacotherapy +12